NEONATAL FC RECEPTOR

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 15:10:12 UTC 2023` Edited by `admin` on `Sat Dec 16 15:10:12 UTC 2023`
Protein Type	RECEPTOR
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	TW3XAW0RCY
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

NEONATAL FC RECEPTOR

Common Name

English

IGG RECEPTOR FCRN LARGE SUBUNIT P51

Common Name

English

FCRN

Common Name

English

IGG FC FRAGMENT RECEPTOR TRANSPORTER ALPHA CHAIN

Common Name

English

Code System Code Type Description

UNIPROT

P55899

Created by admin on Sat Dec 16 15:10:13 UTC 2023 , Edited by admin on Sat Dec 16 15:10:13 UTC 2023

PRIMARY

FDA UNII

TW3XAW0RCY

Created by admin on Sat Dec 16 15:10:13 UTC 2023 , Edited by admin on Sat Dec 16 15:10:13 UTC 2023

PRIMARY

From	To
1_96	1_159
1_198	1_252

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_102

Related Record Type Details


					C98V9UMX3D

BATOCLIMAB

INHIBITOR -> TARGET


					STH9Q2G9H9

TIFALIBEP

LIGAND->TARGET


					O8DG8VI95O

SEMORINEMAB

LIGAND->TARGET


					961YV2O515

EFGARTIGIMOD ALFA

INHIBITOR -> TARGET

Comments:

An antibody fragment that binds to the neonatal Fc receptor (FcRn), preventing FcRn from recycling immunoglobulin G (IgG) back into the blood.[2] The medication causes a reduction in overall levels of IgG, including the abnormal acetylcholine receptor (AChR) antibodies that are present in myasthenia gravis.

Amount:


					OV18TY1BGB

PRV-3279

BINDER->LIGAND


					GN5XU2DXKV

ROMIPLOSTIM

LIGAND->TARGET


					1LTT6HMX9N

ORILANOLIMAB

INHIBITOR -> TARGET


					P7186074QC

Rozanolixizumab

INHIBITOR -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL